Instituto de Investigación e Innovación en Ciencias Biomédicas (INiBICA)
Instituto de investigación
Universidad Complutense de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Complutense de Madrid (95)
2024
-
Amantadine and/or transcranial magnetic stimulation for fatigue associated with multiple sclerosis (FETEM): study protocol for a phase 3 randomised, double-blind, cross-over, controlled clinical trial
BMJ Open, Vol. 14, Núm. 1, pp. e078661
-
Gender-modulated relationships among depression, light household tasks and physical activity: population-based moderation analysis
Journal of Public Mental Health, Vol. 23, Núm. 1, pp. 76-91
-
Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia
Schizophrenia Research, Vol. 267, pp. 24-31
-
N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia
Translational Psychiatry, Vol. 14, Núm. 1
-
Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study
Spanish Journal of Psychiatry and Mental Health
-
THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation
Psychiatry Research, Vol. 331
2023
-
Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up
International Journal of Neuropsychopharmacology, Vol. 26, Núm. 11, pp. 796-807
-
Correlation Between Opioid Drug Prescription and Opioid-Related Mortality in Spain as a Surveillance Tool: Ecological Study
JMIR public health and surveillance, Vol. 9, pp. e43776
-
Hippocampal subfield abnormalities and biomarkers of pathologic brain changes: from SARS-CoV-2 acute infection to post-COVID syndrome
eBioMedicine, Vol. 94
-
Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patients
Revista de Psiquiatria y Salud Mental
-
Progressive loss of cortical gray matter in first episode psychosis patients with auditory hallucinations
Schizophrenia Research
-
Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study
European Neuropsychopharmacology, Vol. 67, pp. 53-65
-
The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)
Frontiers in Microbiology, Vol. 14
-
The polygenic basis of relapse after a first episode of schizophrenia
European Neuropsychopharmacology, Vol. 75, pp. 80-92
-
Value of NT-proBNP and Galectin-3 as Biomarkers in the Follow-Up of Asymptomatic Elderly Patients with Severe Aortic Stenosis
Journal of Clinical Medicine, Vol. 12, Núm. 8
2022
-
Epigenetic clocks in relapse after a first episode of schizophrenia
Schizophrenia, Vol. 8, Núm. 1
-
Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients
Schizophrenia, Vol. 8, Núm. 1
-
Neurocognitive and emotional status after one-year of mindfulness-based intervention in patients with relapsing-remitting multiple sclerosis
Applied Neuropsychology:Adult, Vol. 29, Núm. 2, pp. 183-192
-
Relapse of first-episode schizophrenia patients and neurocognitive impairment: The role of dopaminergic and anticholinergic burden
Schizophrenia Research, Vol. 248, pp. 331-340
-
Sex and substance use in first episode psychosis: Impact on clinical symptoms, psychosocial functioning and cognitive performance
Revista de Psiquiatria y Salud Mental